Personalized medicine startup files for $100M initial public offering, but analyst says move could be prelude to an acquisition by a major life sciences company.
|
Cabilly patent overturned; FDA wants new Xolair warning; Avastin sales threatened.
|
JPMorgan's annual healthcare confab. highlights trends and themes shaping the sector.
|
Investors look to get insight on the medical device industry’s coming year with top chief Art Collins.
|
Year in Review: Innovation and controversy defined the medical technology industry.
|
The heart device company hopes to raise funds to pump into drug-eluting stents.
|
Humanitarian organization appeals to Abbott and looks for help from generic drugmakers.
|
Conor Medsystems implants the first patient with a dual-drug heart device.
|
Abbott’s diagnostic lung cancer deal; cataract removal device study to start.
|
Boston Scientific gets U.S. government clearance to acquire troubled heart device maker Guidant.
|
Europe probes Boston-Guidant deal; Inamed’s outperforming wrinkle filler; polls shows Americans like techy medicine.
|
Inspectors say heart device maker failed to report in a timely manner on repair work for certain defibrillator products.
|
BSX files for merger clearance; Allergan extends Inamed offer; NUCRYST wound dressing goes to Europe.
|
Heart device maker terminates agreement with Johnson & Johnson after the deadline expires for raised bid.
|
An FDA advisory panel recommends Glaxo’s drug Alli become the first over-the-counter weight-loss drug.
|
CEO of GTC Biotherapeutics says his firm is rearing transgenic goats that will lead to a drug to treat blood-clotting problems.
|
Rigel stock on the upswing; Salix inks $37M-license deal; Abbott’s bipolar drug approved.
|
Texas suit, and another by the EFF, allege Sony BMG installed spyware through its CDs.
|
The health care company agrees to pay Cambridge Antibody Technology the sum instead of future royalties.
|
Manograms for prostate cancer; Abbott glucose meters can be misused; cancer diagnostics growing to $7.4B.
|
Page
1
of
2
|